Resistance in the land of molecular cancer therapeutics. [electronic resource]
Producer: 20030515Description: 99-102 p. digitalISSN:- 1535-6108
- Antineoplastic Agents -- administration & dosage
- Benzamides
- Disease Progression
- Drug Resistance, Neoplasm -- genetics
- Fusion Proteins, bcr-abl -- chemistry
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Mutation
- Piperazines -- administration & dosage
- Pyrimidines -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.